Enlivex Therapeutics
ENLV
ENLV
4 hedge funds and large institutions have $116K invested in Enlivex Therapeutics in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
+$11K |
| 2 |
Renaissance Technologies
New York
|
+$10.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$4K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $101K | +$10.5K | +1,687 | +12% |
|
|
VF
2
Virtu Financial
New York
| $11K | +$11K | +1,763 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $4K | +$4K | +615 | New |
|
|
4
Morgan Stanley
New York
| – | -$1K | -63 | Closed |
|